ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 1 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $57,487,566 | +21.6% | 4,375,005 | +16.6% | 0.19% | +25.7% |
Q2 2023 | $47,269,744 | +5.8% | 3,751,567 | +9.6% | 0.15% | -2.6% |
Q1 2023 | $44,679,690 | +31.5% | 3,423,731 | +77.7% | 0.16% | +20.0% |
Q4 2022 | $33,988,646 | +70.9% | 1,926,794 | +47.5% | 0.13% | +64.6% |
Q3 2022 | $19,893,000 | +3414.7% | 1,306,182 | +4173.7% | 0.08% | +3850.0% |
Q2 2021 | $566,000 | -82.0% | 30,563 | -85.4% | 0.00% | -80.0% |
Q1 2021 | $3,142,000 | – | 209,263 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |